help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bivens, C. L. M.
Right arrow Articles by Olster, D. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bivens, C. L. M.
Right arrow Articles by Olster, D. H.
Endocrinology Vol. 138, No. 1 143-148
Copyright © 1997 by The Endocrine Society


ARTICLES

Abnormal Estrous Cyclicity and Behavioral Hyporesponsiveness to Ovarian Hormones in Genetically Obese Zucker Female Rats1

Carrie Lynn Marín Bivens and Deborah H. Olster

Department of Psychology, University of California, Santa Barbara, California 93106

Address all correspondence and requests for reprints to: Dr. Deborah H. Olster, Department of Psychology, University of California, Santa Barbara, California 93106. E-mail: olster{at}psych.ucsb.edu


    Abstract
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Obese Zucker female rats are infertile. The present study was designed to assess estrous cyclicity in adult, ovary-intact, lean and obese Zucker rats and to compare reproductive behaviors induced by exogenous steroid hormones in ovariectomized (ovx) lean and obese Zucker rats. The majority (90%) of obese rats had incomplete cycles in comparison with the normal, 4-day cycles displayed by lean Zucker rats. After ovariectomy, all rats were treated with estradiol benzoate (EB, 15–100 µg/kg) or EB plus progesterone (P, 2–20 mg/kg), and tested for sexual receptivity and proceptivity (PRO). At the highest EB dose, obese Zucker females displayed lordosis less frequently than lean rats (lordosis quotient, LQ, 8 ± 6% vs. 32 ± 13%, respectively). At the lowest doses of EB plus P, lean females were extremely receptive and proceptive (LQ = 93 ± 4%, PRO = 6.2 ± 2 bouts/min). Zucker obese females, in contrast, were only slightly receptive (LQ = 26 ± 11%) and showed less PRO than lean rats (PRO = 2.4 ± 0.6 bouts/min). Increasing the dose of either EB or P, administered in combination with the lowest dose of the other hormone, produced receptivity and PRO in obese Zucker females that were comparable with those observed in lean rats. Serum estradiol and P levels in ovx obese rats were either equivalent to or higher than those in the ovx lean rats when both were given the same doses of hormones. These data suggest that considerably higher doses and serum concentrations of EB and/or P are required to elicit robust lordosis and PRO in ovx obese Zucker than in lean rats. This behavioral hyporesponsiveness to sex steroid hormones may contribute to infertility in the obese Zucker female rat.


    Introduction
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
FOOD availability is a regulator of reproduction in mammals. Food restriction in female rats delays pubertal onset (1, 2, 3), suppresses pulsatile gonadotropin secretion (1, 3), induces abnormal estrous cycles (3), and inhibits reproductive behavior (3). Although the link between undernutrition and suppressed reproductive function is well established, the connection between obesity and infertility has not been as thoroughly explored.

The obesity in Zucker rats is inherited as a Mendelian, homozygous recessive trait (fa/fa) (4). Genetically obese Zucker rats have several endocrine and metabolic abnormalities, including low metabolic rate (5), hyperinsulinemia (6, 7), corticosterone overproduction (8, 9), and infertility (4). Obese rats are produced typically by breeding heterozygous (+/fa) lean rats (4) (Charles River Laboratories, personal communication; Harlan Sprague Dawley, personal communication) or by breeding heterozygous (+/fa) females with fertile obese (fa/fa) male rats (R. Oates-O’Brien, University of California, Davis, personal communication). However, only a few male obese Zucker rats are fertile (4, 10), and all obese Zucker female rats are infertile (4). Obese female rats have delayed puberty, as indicated by delayed vaginal opening (11, 12, 13), subsequent abnormal estrous cyclicity (11, 12, 14), undeveloped uteri and lack of deciduomata formation (11, 15), a lack of mechanically induced pseudopregnancy, and low pituitary weight (15). Only a small subset of obese Zucker rats displays normal estrous cycles (14, 16, 17) and shows normal pseudopregnancy and deciduomata responses (16).

Ovary-intact and PMS-treated, obese Zucker, female rats display less reproductive behavior than their lean counterparts (4, 11, 15). This evidence suggests that obese Zucker female rats may be behaviorally hyporesponsive to the inductive effects of gonadal steroid hormones. To test this hypothesis, we compared reproductive behavior induced by exogenous steroid hormones in ovariectomized (ovx) lean and obese Zucker rats. Serum steroid hormones were measured after estradiol benzoate (EB) and progesterone (P) treatment to rule out the possibility that low circulating hormone levels in steroid-treated, obese rats could have produced suboptimal reproductive behaviors.


    Materials and Methods
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Animals
Nine-week-old, heterozygous, lean (fa/+, n = 10) and obese (fa/fa, n = 21) female rats were purchased from the Department of Nutrition, University of California, Davis, CA. Sexually experienced, Long-Evans, male rats (4–6 months old, 500–670 g, from Charles River Laboratories, Wilmington, MA) were used as stimulus males for the behavioral tests. All animals were housed singly in a room with ambient temperature at 22–23 C and a 14-h light/10-h dark photoperiod (lights on 2300 h–1300 h). They were given unlimited access to food (Rodent Chow no. 5001, PMI Feeds, St. Louis, MO) and water. All procedures were approved by the University of California, Santa Barbara Animal Care Council, and followed the guidelines established by the NIH Guide for the Care and Use of Laboratory Animals.

Estrous cycles, hormone treatments, and behavioral testing
After a 1-week recovery period from traveling, vaginal smears were collected each morning (1000 h) by lavage from all females for 2 weeks to determine estrous cyclicity (18). In this classification, the term metestrus is omitted and replaced with diestrus I because metestrus has a rather short duration and is not consistently observed. The investigator classified all vaginal smears without knowledge of genotype. After estrous cyclicity data were collected, the female rats were anesthetized with 33.3 mg/kg ketamine (im) plus 6.7 mg/kg xylazine (im) and were ovx bilaterally with caution to prevent excessive adipose tissue removal. Behavioral testing began after all rats returned, at least, to their presurgical weights (16 days post surgery).

Ovx lean females received EB (Sigma, St. Louis, MO; 15, 50, 100 µg/kg sc) dissolved in sesame oil, followed 24 h later by P (Sigma; 2 mg/kg sc) dissolved in propylene glycol. Obese females received either EB (15, 50, 100 µg/kg sc) followed 24 h later by P (2 mg/kg sc; n = 10), or EB (15 µg/kg sc) followed 24 h later by P (2, 4, 20 mg/kg sc; n = 11). The different hormone doses were given to all animals in a counterbalanced order, with a 2-week recovery period between hormone treatments. Animals were tested for the display of reproductive behaviors in response to stimulus males, which were physically larger than obese females, immediately before and 4 h after P treatment. A dim red light (25 W) provided illumination during testing (1400–2200 h). Reproductive behaviors were observed in clear Plexiglas cylinders (46 cm x 92 cm, American Plastics Corp., Camarillo, CA) with pine shavings on the floor. Sexual receptivity was quantified by lordosis quotient (LQ, positive lordosis responses/number of mounts x 100%) and lordosis rating [LR, average degree of arching of the back using the following criteria: 0 = no lordosis, 1 = slight, 2 = moderate, 3 = strong dorsioflexion; (19)]. Proceptivity (PRO) rate was measured as the frequency of ear-wiggling and hop-darting bouts. The observer was unaware of treatment conditions during these behavioral observations.

Blood collection
Another group of ovx lean (n = 10) and obese (n = 12) rats were catheterized in the right jugular vein using the anesthesia described previously. The catheters were made from 0.025"-id x 0.047"-od silicon rubber tubing (Sil-Med Corp., Tauton, MA). The catheter extended 34 mm into the jugular vein, was led sc around the shoulder to the back of the neck, protruded 2.5 cm from the neck, and was sealed with a stainless steel pin. The catheters were flushed daily with heparin (100 IU/ml in 0.9% saline) to maintain patency. At the onset of the dark phase, 2 days after catheterization, a 0.5-ml blood sample was removed and replaced with 0.5 ml sterile 0.9% saline. Next, the rats were treated with either 15 or 50 µg/kg EB, sc. Every 4 h post injection, a 0.5-ml blood sample was collected and replaced with 0.5 ml sterile 0.9% saline, without restraining the rats. If catheters failed, samples were collected from the tail vein, with restraint. After the seventh blood sample was collected (i.e. 24 h after EB injection), either 2 or 4 mg/kg P was injected sc. Four hours later, a final 2-ml blood sample was collected. A dim red light (25 W) provided illumination during the dark phase of the photoperiod, and noise was minimized. Sera were harvested and stored at -20 C until used in RIAs.

RIA
Serum estradiol and P levels were measured in duplicate 50-µl samples by RIA using Coat-A-Count RIA kits (Diagnostics Products Corp., Costa Mesa, CA). We first verified that these kits do not require extraction or chromatography, even from hyperlipidemic serum samples (data not shown). For the estradiol RIA, the assay sensitivity was 8 pg/ml and the intra- and interassay coefficients were 2.4% and 7.3%, respectively (n = 4 assays). The sensitivity for the P RIA was 0.02 ng/ml and the intra- and interassay coefficients were 0.8% and 3.6%, respectively (n = 2 assays).

Data analysis
Estrous cyclicity data were analyzed by chi-square analysis for normal estrous cycles (normal = 4- to 5-day cycles, abnormal = diestrus > 2 days, prolonged estrus, or incomplete cyclicity). Mixed-measures ANOVA and post hoc comparisons were used to analyze the RIA data and proceptive behavioral data for effects of genotype, hormone dose, and time, when appropriate. Friedman’s two-way ANOVA and multiple comparisons (hormone dose effects) and Mann-Whitney U test (genotype effects) were used to evaluate the sexual receptivity data (20). The criterion for statistical significance was P < 0.05 for all tests. The statistical software program BMDP (1993 version, programs 2V, 4V, 7D, 3S) was used for all analyses.


    Results
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Estrous cyclicity
All ovary-intact lean rats had normal, 4-day estrous cycles, whereas only 10% of the obese rats had normal cycles (Fig. 1Go, {chi}2 = 8081, P < 0.05). Representative examples of abnormal cycles are shown in Fig. 1Go. Most (75%) obese rats displayed alternating single days of estrus and multiple days of diestrus, whereas some were in constant diestrus (15%). Oddly, one rat had a backward cycle, with estrus followed by proestrus instead of diestrus (Fig. 1Go).



View larger version (26K):
[in this window]
[in a new window]
 
Figure 1. Patterns of representative daily vaginal smears with percent lean and obese Zucker rats displaying that specific vaginal smear pattern. All lean rats displayed normal 4-day estrous cycles, whereas most obese rats exhibited aberrant cycles. P, proestrus; E, estrus; D1, 1st day of diestrus; D2, 2nd day of diestrus.

 
Sex behavior
After injection of EB alone, lordosis responses were low in both lean and obese ovx rats. At the highest dose of EB, obese rats displayed lordosis less frequently than the lean rats (Fig. 2Go, Mann-Whitney U = 81.5, P < 0.05). When the obese rats displayed estradiol-induced sexual receptivity, it was less robust than that observed in lean rats, as assessed by LR (Fig. 2Go, Mann-Whitney U = 85.5, P < 0.05). Proceptive behaviors were never observed in either group after treatment with EB alone.



View larger version (20K):
[in this window]
[in a new window]
 
Figure 2. LQ (top) and LR (bottom) in ovx lean and obese females after various doses of EB. **, P < 0.01; *, P < 0.05 vs. lean rats at same EB dose.

 
At the lowest doses of EB (15 µg/kg) plus P (2 mg/kg), lean rats were significantly more receptive and proceptive than obese rats [Fig. 3Go, LQ, Mann-Whitney U = 102, P < 0.05; LR, Mann-Whitney U = 99.0, P < 0.05; PRO, F (1, 19) = 5.31, P < 0.05]. Increasing the dose of EB while keeping the P dose constant induced LQs, but not LRs, in obese rats comparable with those observed in lean rats treated with the same dose of hormones (Fig. 3Go, LR, Mann-Whitney U = 80.00, P > 0.1; LQ, Mann-Whitney U = 91.0, P < 0.05). Proceptive behaviors were lower in obese rats after either the lowest (15 µg/kg) or the highest (100 µg/kg) EB dose combined with 2 mg/kg P [F (1, 19) = 5.31, P < 0.05]. Increasing the P dose, while keeping EB at the lowest dose, enhanced sexual receptivity (both LQ and LR) and PRO in obese rats to the level displayed by lean rats receiving any dose of EB plus 2 mg/kg P (Fig. 3Go, Mann-Whitney U = 66.00, P > 0.05).



View larger version (26K):
[in this window]
[in a new window]
 
Figure 3. LQ (top), LR (middle) and PRO rate (bottom) in ovx lean and obese females after treatment with varying doses of EB plus P. **, P < 0.01; *, P < 0.05 vs. lean rats receiving the same hormone dose.

 
Circulating steroid hormones
Baseline levels of circulating estradiol did not differ in ovx lean and obese rats. After injection of either EB dose, serum estradiol levels peaked at 4–8 h and declined gradually in both lean and obese rats. Strikingly, obese rats had substantially higher serum estradiol concentrations at each time point than lean rats when treated with the same dose of EB [Fig 4Go., F (1, 14) = 43.45, P < 0.05].



View larger version (33K):
[in this window]
[in a new window]
 
Figure 4. Serum estradiol concentrations (top) and serum P concentrations (bottom) in ovx lean and obese females after treatment with EB (15 or 50 µg/kg) or P (2 or 4 mg/kg). **, P < 0.01; *, P < 0.05 vs. lean rats receiving the same hormone dose and at the same time point.

 
Baseline levels of P were higher in obese rats as compared with lean rats [F(1, 14) = 7.14, P < 0.05]. Four h after injecting the lowest P dose (2 mg/kg), serum P levels increased from baseline and were similar in lean and obese rats (Tukey’s post hoc comparison P > 0.05). However, four h after injection of the higher P dose (4 mg/kg), obese rats had higher serum P levels than lean rats [F (1, 14) = 7.14, P < 0.05].


    Discussion
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Estrous cyclicity
The vaginal smear data confirm previous findings that estrous cyclicity is abnormal in obese Zucker rats (11, 12, 14). Although obese rats exhibited prolonged diestrus, the abnormality may not be simply an increase in cycle length, as previously suggested, because many animals seemed to skip stages. Alternatively, the stages may be shortened so that a daily vaginal lavage misses a short stage. These findings suggest abnormal endogenous steroid production in obese rats, possibly in response to abnormal gonadotropin secretion or impaired vaginal epithelial response to estradiol. Endogenous steroid production in obese rats with normal 4-day cycles is similar to that found in ovary-intact lean rats but has yet to be measured in abnormally cycling obese rats (14). Yet, few (10%) obese rats in our study showed normal, 4-day estrous cycles.

Steroid-induced, reproductive behavior
Besides abnormal estrous cyclicity, obese Zucker rats were behaviorally hyporesponsive to the effects of exogenous steroid hormones. Obese rats displayed significantly less P-facilitated receptivity and PRO at the lowest combined doses of EB plus P, a hormonal regimen that induced maximal reproductive behavior in lean rats. Raising the EB dose, while maintaining the P dose constant, induced receptivity in obese rats to levels similar to those seen in lean rats. Maintaining the lowest EB dose and raising the P dose increased both receptivity and PRO in obese rats to levels similar to those observed in lean rats. This finding is not surprising because P facilitates solicitation behaviors in estradiol-primed, ovx rats (21).

These results suggest that considerably higher doses of estradiol and P are necessary to elicit robust sexual receptivity and PRO in ovx obese rats as compared with lean rats. This may be part of a general hyporesponsiveness of obese Zucker female rats to ovarian hormones. Not only are female obese rats hyporesponsive to gonadal steroid hormone effects on sex behavior, they are hyporesponsive to estradiol’s suppressive effects on feeding (22, 23) and body weight (23). Yet, ovariectomy increases body weight (23), feeding (23), and gonadotropin secretion (11) in obese Zucker rats, suggesting that obese rats secrete estradiol and that both their hypothalamic-pituitary axis and neural systems mediating-feeding behavior are sensitive to it.

The behavioral hyporesponsiveness of obese Zucker females after exogenous hormone treatment was not caused by lower serum concentrations of hormones. Circulating concentrations of estradiol after EB injection were higher in obese than in lean rats. After the lowest EB dose (15 µg/kg), serum estradiol levels observed in both lean and obese Zucker rats were within physiological levels for female rats on the night of proestrus (14, 24). Serum P levels after P injection were equivalent or higher in obese rats, although their baseline P levels were 50% higher than those observed in ovx lean females. Presumably, the adrenal glands, which are overactive in obese rats, overproduce progestins (8, 9, 25, 26). Obese rats sequester less 3H-P in adipose tissue than lean rats (27), which may contribute to their elevated serum P levels. Although serum estradiol and P levels achieved by injections of the same doses were equivalent or higher in obese rats, it is possible that abnormalities in sex hormone-binding proteins could alter free steroid hormone levels and subsequent induction of sexual behavior. We cannot address this possibility because we used estradiol and P RIAs that measured total serum steroid hormones.

Estrogen receptors and estrogen-induced progestin receptors in specific diencephalic brain areas mediate the effects of estradiol and P on reproductive behaviors (28). Cytosol estrogen receptor concentrations in the whole hypothalamus and preoptic area are similar in lean and obese Zucker rats (29). Additionally, sufficient estradiol apparently reaches the brain in obese rats because EB treatment (5 µg sc) induces greater concentrations of cytosol progestin receptors in the preoptic area and hypothalamus of obese than in those of lean Zucker rats (30). Binding affinities for cytosol estrogen and progestin receptors seem comparable between lean and obese genotypes (27, 29). Although hypothalamic cytosol estrogen and progestin receptors seem functional in obese rats, it is possible that cell nuclear estrogen and progestin receptor accumulation may be inadequate.

There are many other documented abnormalities in obese Zucker rats that might contribute to reproductive dysfunction. For instance, the overactive hypothalamic-pituitary-adrenal axis (8, 9, 25, 26) in obese Zucker rats may lead to diminished reproductive capacity. CRH can suppress sex behavior in female rats when injected into the mediobasal hypothalamus and midbrain central gray (31). Short-term administration of CRH suppresses LH release in ovx rats, which presumably could lead to abnormal estrous cyclicity (32). However, obese rats have similar CRH and CRH messenger RNA (mRNA) levels in the paraventricular nucleus of the hypothalamus and lower CRH levels in the median eminence and pituitary as compared with lean rats (33, 34, 35). Thus, it seems unlikely that CRH release or overproduction in the hypothalamus leads to their behavioral hyporesponsiveness to exogenous steroid hormones. Corticosterone overproduction, which occurs in obese Zucker rats, could disrupt reproductive behaviors because chronic corticosterone treatment decreases sexual receptivity in female rats (36, 37, 38).

Another feasible explanation, although counterintuitive, for the abnormal physiological and behavioral responses in obese Zucker rats to exogenous steroid hormone treatment, is that obese Zucker rats behave similarly to calorically deprived, instead of calorically abundant, rodents. For example, both obese Zucker rats and food-deprived animals have similar food intake patterns (i.e. large meals, slight increase in meal frequency), have increased neuropeptide Y (NPY) levels and synthesis in the hypothalamus (39, 40, 41), are hyporesponsive to the inductive effects of exogenous steroid hormones on reproductive behavior (42), and have elevated circulating estradiol and P after treatment with exogenous steroid hormones (43). However, food deprivation does alter concentrations of estrogen and progestin receptors in the hypothalamus and preoptic area (44, 45). These similar behavioral and physiological responses between food-deprived rodents and obese Zucker rats suggest that obese Zucker rats may respond as if they exist in a state of starvation.

Finally, the abnormal estrous cyclicity and behavioral hyporesponsiveness to sex-steroid hormones displayed by obese rats may be triggered by hyperactive neurotransmitter systems that are inhibitory to reproductive behavior and estrous cyclicity, such as NPY and endogenous opioids. NPY mRNA is overproduced in the arcuate nucleus of female obese Zucker rats (39), which probably contributes to the higher tissue levels of NPY in other diencephalic areas such as the ventromedial hypothalamus (41), medial preoptic area (40), paraventricular nucleus (40, 41), and suprachiasmatic nucleus (40, 41). NPY overproduction in obese Zucker rats may be produced by dysfunctional negative-feedback mechanisms of both leptin and insulin on NPY synthesis (46, 47, 48). Chronic injection of NPY in female rats disrupts estrous cyclicity by prolonging diestrus (49). Intraventricular injections of NPY suppress sexual receptivity and PRO in either estrogen- or estrogen-plus-P-primed, spayed female rats (50). Likewise, the concentration of the endogenous opioid, ß-endorphin, and its precursor, POMC, is higher in whole brain and pituitary of obese, as compared with lean, Zucker rats (25, 51, 52). ß-endorphin regulates gonadotropin secretion (53), and its disruption could lead to abnormal estrous cyclicity. Furthermore, peripheral and central ß-endorphin injections suppress sexual behavior in female rats (54, 55, 56). Work from this laboratory suggests that destruction of the arcuate nucleus of the hypothalamus, where both NPY and ß-endorphin are produced, decreases body weight and feeding and increases sex behavior in obese Zucker rats (57). These data support the hypothesis that overproduction of NPY or opioids may contribute to behavioral hyporesponsiveness to gonadal steroid hormones observed in obese rats.

In conclusion, we have documented that estrous cyclicity is abnormal in most genetically obese Zucker rats. We found that steroid-treated ovx obese rats are behaviorally hyporesponsive to doses of exogenous steroid hormones that induce maximal responsiveness in lean rats. Considerably higher doses and circulating concentrations of estradiol and P are required to elicit robust sexual receptivity and PRO in ovx obese Zucker rats. This behavioral hyporesponsiveness to ovarian hormones may contribute to infertility in the obese Zucker female rat.


    Acknowledgments
 
Our gratitude and appreciation are bestowed to Jack B. Calderone and Tara Marchand for their editorial commentary on previous versions of this manuscript.


    Footnotes
 
1 This work was supported by NIH Grant HD-28636 (to D.H.O.) and a predoctoral Minority Fellowship in Neuroscience from the American Psychological Association (to C.L.M.B.). Back

Received June 10, 1996.


    References
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 

  1. Bronson FH 1986 Food-restricted, prepubertal, female rats: rapid recovery of luteinizing hormone pulsing with excess food, and full recovery of pubertal development with gonadotropin-releasing hormone. Endocrinology 118:2483–2487[Abstract/Free Full Text]
  2. Bronson FH 1987 Puberty in female rats: relative effect of exercise and food restriction. Am J Physiol 252:R140–R144
  3. Wade GN, Schneider JE 1992 Metabolic fuels and reproduction in female mammals. Neurosci Biobehav Rev 16:235–272[CrossRef][Medline]
  4. Zucker LM, Zucker TF 1961 Fatty, a new mutation in the rat. J Hered 52:275–278[Free Full Text]
  5. Bray GA 1977 The Zucker-fatty rat: a review. Fed Proc 36:148–153[Medline]
  6. Zucker LM, Antoniades HN 1972 Insulin and obesity in the Zucker genetically obese rat ("fatty"). Endocrinology 90:1320–1330[Abstract/Free Full Text]
  7. Stern J, Johnson PR, Greenwood MR, Zucker LM, Hirsch J 1972 Insulin resistance and pancreatic insulin release in the genetically obese Zucker rat. Proc Soc Exp Biol Med 139:66–69[CrossRef][Medline]
  8. Castonguay TW 1991 Glucocorticoids as modulators in the control of feeding. Brain Res Bull 27:423–428[CrossRef][Medline]
  9. Martin RJ, Gahagan JH 1977 The influence of age and fasting on serum hormones in the lean and obese-Zucker rat. Proc Soc Exp Biol Med 154:610–614[CrossRef][Medline]
  10. Hemmes RB, Hubsch S, Pack HM 1978 High dosage of testosterone propionate increases litter production of the genetically obese male Zucker rat (40362). Proc Soc Exp Biol Med 159:424–427[CrossRef][Medline]
  11. Saiduddin S, Bray GA, York DA, Swerdloff RS 1973 Reproductive function in the genetically obese "fatty" rat. Endocrinology 93:1251–1256[Abstract/Free Full Text]
  12. Chelich AM, Edmonds ES 1980 Reproduction function in the genetically obese Zucker rat. Anat Rec 196:264
  13. Powley TL, Morton SA 1976 Hypophysectomy and regulation of body weight in the genetically obese Zucker rat. Am J Physiol 230:982–987[Abstract/Free Full Text]
  14. Whitaker EM, Shaw MA, Hervey GR 1983 Plasma oestradiol-17ß and testosterone concentrations as possible causes of the infertility of congenitally obese Zucker rats. J Endocrinol 99:485–490[Abstract/Free Full Text]
  15. Bray GA, York DA, Swerdloff RS 1973 Genetic obesity in rats. I. The effects of food restriction on body composition and hypothalamic function. Metabolism 22:435–442[CrossRef][Medline]
  16. Chelich AM, Edmonds ES 1986 Pseudopregnancy and the decidual response in the obese Zucker rat: a reexamination. Biol Reprod 34:805–808[Abstract]
  17. Chelich AM, Edmonds ES 1981 Copulatory behavior and reproductive capacity of the genetically obese female Zucker rat. Physiol Behav 27:331–335[CrossRef][Medline]
  18. Everett JW 1989 Neurobiology of reproduction in the female rat. A fifty year perspective. Monogr Endocrinol 32:1–133[Medline]
  19. Powers JB, Valenstein ES 1972 Sexual receptivity: facilitation by medial preoptic lesions in female rats. Science 175:1003–1005[Abstract/Free Full Text]
  20. Siegel S, Castellan NJ 1988 Nonparametric Statistics for the Behavioral Sciences, ed 2. McGraw-Hill, New York
  21. Erskine MS 1989 Solicitation behavior in the estrous female rat: a review. Horm Behav 23:473–502[CrossRef][Medline]
  22. Bray GA, Saiduddin S, York DA, Swerdloff RS 1976 Effect of estradiol on uterine weight, thyroid function, food intake, and pituitary weight of genetically obese (fatty-Zucker) and lean rats. Proc Soc Exp Biol Med 153:88–91[CrossRef][Medline]
  23. Gale SK, Van Itallie TB 1979 Genetic obesity: estrogenic influences on the body weight and food intake of lean and obese adult Zucker (fa/fa) rats. Physiol Behav 23:111–120[CrossRef][Medline]
  24. Butcher RL, Collins WE, Fugo NW 1974 Plasma concentrations of LH, FSH, prolactin, progesterone, and estradiol-17ß throughout the 4-day estrous cycle of the rat. Endocrinology 94:1704–1708[Abstract/Free Full Text]
  25. Gibson MJ, Liotta AS, Krieger DT 1981 The Zucker fa/fa rat: absent circadian corticosterone periodicity and elevated beta-endorphin concentrations in brain and neurointermediate pituitary. Neuropeptides 1:349–362[CrossRef]
  26. Martin RJ, Wangsness PJ, Gahagan JH 1978 Diurnal changes in serum metabolites and hormones in lean and obese Zucker rats. Horm Metab Res 10:187–192[Medline]
  27. Saiduddin S, Zassenhaus HP 1979 Uterine progesterone receptor and biological responses to progesterone in the infertile Zucker fatty female rat. Biol Reprod 20:939–945[Abstract]
  28. Blaustein JD, Olster DH 1989 Gonadal steroid hormone receptors and social behaviors. In: Balthazart J (ed) Advances in Comparative and Environmental Physiology. Springer-Verlag, Berlin, vol 3:31–104
  29. Saiduddin S, Zassenhaus HP 1979 Interaction of estradiol with its receptor in the infertile Zucker fatty female rat. Biol Reprod 20:253–260[Abstract]
  30. Gray JM, Greenwood MRC 1984 Effect of estrogen on lipoprotein lipase activity and cytoplasmic progestin binding sites in lean and obese Zucker rats. Proc Soc Exp Biol Med 175:374–379[CrossRef][Medline]
  31. Sirinathsinghji DJ, Rees LH, Rivier J, Vale W 1983 Corticotropin-releasing factor is a potent inhibitor of sexual receptivity in the female rat. Nature 305:232–235[CrossRef][Medline]
  32. Rivier C, Vale W 1984 Influence of corticotropin-releasing factor on reproductive functions in the rat. Endocrinology 114:914–921[Abstract/Free Full Text]
  33. Nakaishi S, Nakai Y, Fukata J, Naito Y, Usui T, Imura H 1990 Immunoreactive corticotropin-releasing hormone levels in brain regions of genetically obese Zucker rats. Int J Obes 14:951–955[Medline]
  34. Nakaishi S, Nakai Y, Fukata J, Naito Y, Usui T, Fukushima M, Jingami H, Nakao K, Imura H 1993 Immunoreactive corticotropin-releasing hormone levels in discrete hypothalamic nuclei of genetically obese Zucker rats. Neurosci Lett 159:29–31[CrossRef][Medline]
  35. Plotsky PM, Thrivikraman KV, Watts AG 1992 Hypothalamic-pituitary-adrenal axis function in the Zucker obese rat. Endocrinology 130:1931–1941[Abstract/Free Full Text]
  36. de Catanzaro D, Knipping RP, Gorzalka BB 1981 Antagonism of estrogen-induced lordosis by corticosterone in adrenalectomized-ovariectomized female rats and mice. Pharmacol Biochem Behav 15:761–766[CrossRef][Medline]
  37. Turner BB, Taylor AN 1977 Effects of postnatal corticosterone treatment on reproductive development in the rat. J Reprod Fertil 51:309–314[Abstract/Free Full Text]
  38. de Catanzaro D 1987 Alteration of estrogen-induced lordosis through central administration of corticosterone in adrenalectomized-ovariectomized rats. Neuroendocrinology 46:468–474[Medline]
  39. Sanacora G, Kershaw M, Finkelstein JA, White JD 1990 Increased hypothalamic content of preproneuropeptide Y messenger ribonucleic acid in genetically obese Zucker rats and its regulation by food deprivation. Endocrinology 127:730–737[Abstract/Free Full Text]
  40. Beck B, Burlet A, Nicolas JP, Burlet C 1990 Hypothalamic neuropeptide Y (NPY) in obese Zucker rats: implications in feeding and sexual behaviors. Physiol Behav 47:449–453[CrossRef][Medline]
  41. McKibbin PE, Cotton SJ, McMillan S, Holloway B, Mayers R, McCarthy HD, Williams G 1991 Altered neuropeptide Y concentrations in specific hypothalamic regions of obese (fa/fa) Zucker rats. Possible relationship to obesity and neuroendocrine disturbances. Diabetes 40:1423–1429[Abstract]
  42. Dickerman RW, Li HY, Wade GN 1993 Decreased availability of metabolic fuels suppresses estrous behavior in Syrian hamsters. Am J Physiol 264:R568–R572
  43. Bronson FH 1988 Effect of food manipulation on the GnRH-LH-estradiol axis of young female rats. Am J Physiol 254:R616–R621
  44. Li HY, Wade GN, Blaustein JD 1994 Manipulations of metabolic fuel availability alter estrous behavior and neural estrogen receptor immunoreactivity in Syrian hamsters. Endocrinology 135:240–247[Abstract]
  45. Du Y, Wade GN, Blaustein JD 1996 Effects of food deprivation on induction of neural progestin receptors by estradiol in Syrian hamsters. Am J Physiol 39:R978–R983
  46. Chua Jr SC, Chung WK, Wu-Peng XS, Zhang Y, Liu SM, Tartaglia L, Leibel RL 1996 Phenotypes of mouse diabetes and rat fatty due to mutations in the OB (leptin) receptor [see comments]. Science 271:994–996[Abstract]
  47. Stephens TW, Basinski M, Bristow PK, Bue-Valleskey JM, Burgett SG, Craft L, Hale J, Hoffmann J, Hsiung HM, Kriauciunas A, Mac Kellar W, Rosteck PR, Schoner B, Smith D, Tinsley FC, Zhang XY, Heiman M 1995 The role of neuropeptide Y in the antiobesity action of the obese gene product. Nature 377:530–532
  48. Schwartz MW, Marks JL, Sipols AJ, Baskin DG, Woods SC, Kahn SE, Porte JR D 1991 Central insulin administration reduces neuropeptide Y mRNA expression in the arcuate nucleus of food-deprived lean (Fa/Fa) but not obese (fa/fa) Zucker rats. Endocrinology 128:2645–2647[Abstract/Free Full Text]
  49. Catzeflis C, Pierroz DD, Rohner-Jeanrenaud F, Rivier JE, Sizonenko PC, Aubert ML 1993 Neuropeptide Y administered chronically into the lateral ventricle profoundly inhibits both the gonadotropic and the somatotropic axis in intact adult female rats. Endocrinology 132:224–234[Abstract/Free Full Text]
  50. Clark JT, Kalra PS, Kalra SP 1985 Neuropeptide Y stimulates feeding but inhibits sexual behavior in rats. Endocrinology 117:2435–2442[Abstract/Free Full Text]
  51. Margules D, Moisset M, Lewis H, Shibuga H, Pert C 1978 Beta-endorphin is associated with overeating in genetically obese mice (ob/ob) and rats (fa/fa). Science 202:988–991[Abstract/Free Full Text]
  52. Fukushima M, Nakai Y, Tsukada T, Usui T, Nakaishi S, Naito Y, Tominaga T, Senoo K, Fukata J, Ikeda H, Matsuo T, Imura H1993 Pro-opiomelanocortin messenger RNA levels in anterior pituitaries of female Wistar fatty rats. Int J Obes Relat Metab Disord 17:337–341
  53. Bicknell RJ 1985 Endogenous opioid peptides and hypothalamic neuroendocrine neurones. J Endocrinol 107:437–446[Abstract/Free Full Text]
  54. Wiesner JB, Moss RL 1986 Suppression of receptive and proceptive behavior in ovariectomized, estrogen-progesterone-primed rats by intraventricular beta-endorphin: studies of behavioral specificity. Neuroendocrinology 43:57–62[Medline]
  55. Pfaus JG, Gorzalka BB 1987 Selective activation of opioid receptors differentially affects lordosis behavior in female rats. Peptides 8:309–317[CrossRef][Medline]
  56. Sirinathsinghji DJ 1985 Modulation of lordosis behaviour in the female rat by corticotropin releasing factor, beta-endorphin and gonadotropin releasing hormone in the mesencephalic central gray. Brain Res 336:45–55[CrossRef][Medline]
  57. Bivens CLM, Olster DH Effects of arcuate nucleus lesions on feeding, body weight and reproductive behaviors in genetically obese Zucker rats. Program of the 25th Annual Meeting of The Society for Neuroscience, San Diego CA, 1995 (Abstract)



This article has been cited by other articles:


Home page
J. Nutr.Home page
S. de Assis, M. Wang, S. Goel, A. Foxworth, W. Helferich, and L. Hilakivi-Clarke
Excessive Weight Gain during Pregnancy Increases Carcinogen-Induced Mammary Tumorigenesis in Sprague-Dawley and Lean and Obese Zucker Rats
J. Nutr., April 1, 2006; 136(4): 998 - 1004.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
E. Keen-Rhinehart, S. P. Kalra, and P. S. Kalra
Leptin-Receptor Gene Transfer into the Arcuate Nucleus of Female Fatty Zucker Rats Using Recombinant Adeno-Associated Viral Vectors Stimulates the Hypothalamo-Pituitary-Gonadal Axis
Biol Reprod, July 1, 2004; 71(1): 266 - 272.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
S. Kumano, H. Matsumoto, Y. Takatsu, J. Noguchi, C. Kitada, and T. Ohtaki
Changes in Hypothalamic Expression Levels of Galanin-Like Peptide in Rat and Mouse Models Support That It Is a Leptin-Target Peptide
Endocrinology, June 1, 2003; 144(6): 2634 - 2643.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
C. B. Herath, G. Watanabe, S.-i. Katsuda, M. Yoshida, A. K. Suzuki, and K. Taya
Exposure of Neonatal Female Rats to p-tert-Octylphenol Disrupts Afternoon Surges of Luteinizing Hormone, Follicle-Stimulating Hormone and Prolactin Secretion, and Interferes with Sexual Receptive Behavior in Adulthood
Biol Reprod, April 1, 2001; 64(4): 1216 - 1224.
[Abstract] [Full Text]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
A. K. Panicker and G. N. Wade
Insulin-induced repartitioning of metabolic fuels inhibits hamster estrous behavior: role of area postrema
Am J Physiol Regulatory Integrative Comp Physiol, April 1, 1998; 274(4): R1094 - R1098.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bivens, C. L. M.
Right arrow Articles by Olster, D. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bivens, C. L. M.
Right arrow Articles by Olster, D. H.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals